Does a Magnetic Resonance-Only Pathway Impact Dosimetric and Acute Clinical Outcomes in Prostate Stereotactic Ablative Body Radiotherapy?
AIMS This study aimed to compare prostate target and organs at risk (OAR) volumes, doses, and acute toxicity scores for patients treated with prostate stereotactic ablative body radiotherapy (SABR) using magnetic resonance (MR)-only or MR registered with computed tomography (MR-CT) pathways. MATERIALS AND METHODS A t...